Loss of BRCA1/2 functions impairs homologous recombination (HR), leaving tumor cells reliant on an alternative repair mechanism that is vulnerable to PARP inhibitor, which induces the accumulation of unrepaired DNA damage and cell death [7,8,9,10,11,12,13]. The gene discussed is PARP1; the disease is neoplasm.